Bupivacaine Hydrochloride Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Bupivacaine Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Feb 20, 2018. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-464-31
Dosage Form
Injection
Presentation
Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31)
Initial Posting
Feb 20, 2018

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.